Singapore markets closed

Straits Times Index
3,303.66
+12.96(+0.39%)
S&P 500
5,221.39
-1.29(-0.02%)
Dow
39,502.75
-10.09(-0.03%)
Nasdaq
16,374.97
+34.10(+0.21%)
Bitcoin USD
62,975.00
+1,627.20(+2.65%)
CMC Crypto 200
1,296.86
+36.65(+2.91%)

APLS May 2024 55.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.0500

0.0000

(0.00%)

As of 02:46PM EDT. Market open.

Simply Wall St.
Analysts Are Updating Their Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Estimates After Its First-Quarter Results
There's been a notable change in appetite for Apellis Pharmaceuticals, Inc. ( NASDAQ:APLS ) shares in the week since...
Insider Monkey
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript May 7, 2024 Apellis Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.54 EPS, expectations were $-0.54. Apellis Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good […]
Simply Wall St.
Apellis Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Apellis Pharmaceuticals ( NASDAQ:APLS ) First Quarter 2024 Results Key Financial Results Revenue: US$172.3m (up 284...